Portland, OR, Oct. 03, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Hepatitis C Testing Market size was estimated at $1.3 billion in 2021 and is expected to hit $2.3 billion by 2031, registering a CAGR of 5.3% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Free Sample Report (296 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/18051
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Market Size in 2031 | $2.3 Billion |
| CAGR | 5.3% |
| No. of Pages in Report | 296 |
| Segments Covered | Technique, Test, End-user, and Region. |
| Drivers | Increase in blood transfusion and blood donation activities |
Covid-19 scenario-
- The outbreak of the pandemic heightened the demand for blood transfusions. All throughout the global health crisis, there was a huge demand for blood plasma for the treatment of Covid-19 patients, which in turn impacted the Hepatitis C Testing market positively.
- Surge in demand for hepatitis C testing in blood banks also boosted the market growth.
The global hepatitis C testing market is analyzed across Technique, Test, End-user, and Region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on technique, the immunoassay segment accounted for more than two-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The PCR segment, simultaneously, would cite the fastest CAGR of 6.2% throughout the forecast period.
Based on test, the antibody test segment held nearly three-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The viral load test segment, however, would cite the fastest CAGR of 6.2% throughout the forecast period.
Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/18051
Based on end-user, the hospital and diagnostic laboratory segment contributed to around three-fifths of the global hepatitis C testing market revenue in 2021, and is expected to dominate by 2031. The blood banks segment, on the other hand, would showcase the fastest CAGR of 5.9% throughout the forecast period.
Based on region, the market across North America generated nearly two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, however, would showcase the fastest CAGR of 7.0% during the forecast period. The other regions studied in the report include LAMEA and Europe.
The key market players analyzed in the global hepatitis C testing market report include BIO-RAD laboratories Inc, Cosara Diagnostics Pvt Ltd, Meril Life Sciences Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., PerkinElmer, Qiagen N.V., Abbott Laboratories, Thermo Fisher Scientific Inc, Trivitron Healthcare, and Illumina Inc. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Intravenous Solutions Market by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), by Composition (Carbohydrates, Vitamins and Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Others), by End Users (Hospitals and Clinics, Ambulatory Surgery Centers, Home care settings): Global Opportunity Analysis and Industry Forecast, 2021-2031
Radiation Oncology Market by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Dental Impression Material Market by Material Type (Alginate, Silicone, Polyether, Others), by Application (Restorative & Prosthodontics, Orthodontics), by End-use (Hospitals, Dental Clinics, Research and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
Hair Transplant Market by Procedure (Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE), Combination of FUT and FUE, Others), by Gender (Female, Male), by Service Provider (Hospitals, Dermatology Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031
Cosmetic Surgery Market By Gender (Female, Male), By Age Group (13 to 29, 30 to 54, 55 and above), By Procedure (Breast augmentation, Eyelid surgery, Liposuction, Rhinoplasty, Others), By End User (Ambulatory surgical facility, Hospital and clinic, Office and cosmetic surgical center): Global Opportunity Analysis and Industry Forecast, 2021-2031
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Follow Us on Blog: https://www.globalhealthcareindustry.com/
